SORT BY

FILTER BY

fastest growing stats

also on other fortune lists

100 Fastest-Growing Companies

Courtesy of Eagle Pharmaceuticals

16

Eagle Pharmaceuticals

EGRX

In an era of drug development that’s produced seeming miracles like gene editing and cancer immunotherapy, the business of “injectables” may come across as quaint. But there’s nothing boring about coming up with new ways of mixing and administering therapies in a way that helps patients in novel ways. And there’s certainly nothing boring about a 36% return on shareholder investment in 2018 alone. Eagle Pharmaceuticals is a standout among its specialty pharmaceutical peers for investors, no matter how bread-and-butter its aspirations may seem.

Looking for leads, investment insights, or competitive intelligence?

Location

Woodcliff Lake, N.J.

Industry

Pharmaceuticals

Sector

Health Care

Current Streak

-

Years on List

1

CEO

Scott Tarriff

Revenue and net income for the four quarters ended on or before April 30, 2018. Total return for the period ended June 29, 2018.
Revenue, Net Income
$ millions
Revenue past four quarters ($M)$207
Net Income past four quarters ($M)$32
Growth Rates and Ranks
Revenue 3 Yr Growth Rank1
Revenue 3 Yr Annual Growth Rate109%
EPS 3 Yr Growth Rank1
EPS 3 Yr Annual Growth Rate392%
Total Return 3 Yr Rank97
Total Return 3 Yr Annual Rate-2%
Beat S&P 500 (11.9%)no
P/E Ratio32
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a